Literature DB >> 21738158

Pulling down the plug on atherosclerosis: cooling down the inflammasome.

Göran K Hansson1, Lars Klareskog.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21738158     DOI： 10.1038/nm0711-790

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

Authors:  Philip N Hawkins; Helen J Lachmann; Michael F McDermott
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 2.  The immune system in atherosclerosis.

Authors:  Göran K Hansson; Andreas Hermansson
Journal:  Nat Immunol       Date:  2011-03       Impact factor: 25.606

3.  Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice.

Authors:  R Elhage; A Maret; M T Pieraggi; J C Thiers; J F Arnal; F Bayard
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

4.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.

Authors:  Chun-Jen Chen; Yan Shi; Arron Hearn; Kate Fitzgerald; Douglas Golenbock; George Reed; Shizuo Akira; Kenneth L Rock
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 5.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

Authors:  J Frostegård; A K Ulfgren; P Nyberg; U Hedin; J Swedenborg; U Andersson; G K Hansson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

7.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

8.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

9.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

10.  Molecular identification of a danger signal that alerts the immune system to dying cells.

Authors:  Yan Shi; James E Evans; Kenneth L Rock
Journal:  Nature       Date:  2003-09-07       Impact factor: 49.962
View more
  10 in total

1.  IL-1 and atherosclerosis: a murine twist to an evolving human story.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

Review 2.  Atherosclerosis in psoriatic disease: latest evidence and clinical implications.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

3.  RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality.

Authors:  Lingjun Meng; Wei Jin; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

4.  Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.

Authors:  Kai Yin; Shi-lin Tang; Xiao-hua Yu; Guang-hui Tu; Rong-fang He; Jin-feng Li; Di Xie; Qing-jun Gui; Yu-chang Fu; Zhi-sheng Jiang; Jian Tu; Chao-ke Tang
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

5.  SVEP1 is a human coronary artery disease locus that promotes atherosclerosis.

Authors:  In-Hyuk Jung; Jared S Elenbaas; Arturo Alisio; Katherine Santana; Erica P Young; Chul Joo Kang; Puja Kachroo; Kory J Lavine; Babak Razani; Robert P Mecham; Nathan O Stitziel
Journal:  Sci Transl Med       Date:  2021-03-24       Impact factor: 17.956

6.  Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.

Authors:  Guozhen Cui; Luchen Shan; Lin Guo; Ivan Keung Chu; Guohui Li; Quan Quan; Yun Zhao; Cheong Meng Chong; Zaijun Zhang; Pei Yu; Maggie Pui Man Hoi; Yewei Sun; Yuqiang Wang; Simon MingYuen Lee
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

7.  Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes.

Authors:  Giovanni Cimmino; Loreta Pia Ciuffreda; Giovanni Ciccarelli; Paolo Calabrò; Fiorella Angelica Valeria Ferraiolo; Alessia Rivellino; Raffaele De Palma; Paolo Golino; Francesco Rossi; Plinio Cirillo; Liberato Berrino
Journal:  Front Cardiovasc Med       Date:  2017-02-07

Review 8.  Interaction among inflammasome, autophagy and non-coding RNAs: new horizons for drug.

Authors:  Qinqin Pu; Ping Lin; Zhihan Wang; Pan Gao; Shugang Qin; Luqing Cui; Min Wu
Journal:  Precis Clin Med       Date:  2019-10-01

9.  Interleukin-17 (IL-17) expression is reduced during acute myocardial infarction: role on chemokine receptor expression in monocytes and their in vitro chemotaxis towards chemokines.

Authors:  Maria Troitskaya; Anton Baysa; Jarle Vaage; Kristin L Sand; Azzam A Maghazachi; Guro Valen
Journal:  Toxins (Basel)       Date:  2012-11-30       Impact factor: 4.546

Review 10.  Inflammation and cardiovascular disease: From mechanisms to therapeutics.

Authors:  Abdulhamied Alfaddagh; Seth S Martin; Thorsten M Leucker; Erin D Michos; Michael J Blaha; Charles J Lowenstein; Steven R Jones; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2020-11-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.